Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price


Stock Report

Alexion Pharmaceuticals Inc ALXN

Last Price
$98.41

Day Change
-1.58|-1.58%

As of 18/10/2019
19:59:12 EDT | USD
Minimum 15 Minutes Delay.

Last Close99.99
Day Range97.59 - 100.45
Mkt Cap22.07Bil
52-Wk Range92.56 - 141.86
Yield %-
ISINUS0153511094
Volume1,624,218
P/E16.86
P/S4.95
P/CF15.47

Share Price

Financials
201620172018
More ...
Income Statement
Revenue3,084.003,551.104,131.20
Operating Income793.00804.001,594.60
Net Income399.00443.3077.60
Basic EPS1.781.980.35
Avg. Diluted Shares Outstanding227225225
Balance Sheet
Current Assets2,578.002,953.903,385.00
Non Current Assets10,675.0010,629.4010,546.90
Total Assets13,253.0013,583.3013,931.90
Current Liabilities823.00952.501,174.00
Total Liabilities4,559.004,690.204,766.60
Total Equity8,694.008,893.109,165.30
Cash Flow
Operating Cash Flow1,086.001,115.60426.00
Capital Expenditure-333.00-357.30-213.00
Free Cash Flow753.00758.30213.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

2,656
Key Stats
More ...
Price/Earning TTM16.75
Price/Book2.21
Price/Sales TTM5.03
Rev Growth (3 year avg)16.63
EPS Growth (3 year avg)-
Operating Margin % TTM38.60
Net Margin % TTM1.88
ROE TTM0.86
Debt/Equity0.31
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.